← Open Payments lookup

JENNIFER BAMBACH: Open Payments

NPI 1629502786 · ROSEDALE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$637 in 31 payments from 10 companies in 2025. Trend: 2023 $1,157 · 2024 $758 · 2025 $637

Food & beverage: $637
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$145
Corium, LLC5$106
Collegium Pharmaceutical, Inc.5$86
ABBVIE INC.4$86
Supernus Pharmaceuticals, Inc.4$63
E.R. Squibb & Sons, L.L.C.2$52
Alkermes, Inc.2$36
Teva Pharmaceuticals USA, Inc.1$24
Otsuka America Pharmaceutical, Inc.1$21
Neurocrine BioSciences, Inc.1$18

Products named: CAPLYTA, Azstarys, Jornay PM, VRAYLAR, Qelbree, COBENFY, ARISTADA, AUSTEDO XR.

Industry payments across MD — which companies pay providers there.